Centennial Medical Center

Nashville, Tennessee 37205

6 studies enrolling now · 54 studies all time

What they study most

Acute Coronary Syndrome, Acute Myeloid Leukemia, Acute Myocardial Infarction, Anemia, Anti-Infective Agents, Aortic Stenosis, Severe, Aortic Valve Disease, Aortic Valve Disorder, Aortic Valve Stenosis, Atherosclerosis, Atrial Arrhythmia, Atrial Fibrillation

Studies at this site

• ALLIANCE: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve — Recruiting now
• Tracking Results of Ablations to Combat AF Registry Generation 2 — Recruiting now
• The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR — Recruiting now
• MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions — Recruiting now
• Delirium Reduction With Ramelteon — Recruiting now
• SPYRAL AFFIRM Global Study of RDN With the Symplicity Spyral RDN System in Subjects With Uncontrolled HTN — Running, not enrolling
• CHAMPION-AF Clinical Trial — Running, not enrolling
• A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE — Running, not enrolling
• SPYRAL HTN-ON MED Study of Renal Denervation With the Symplicity Spyral™ Multi-electrode Renal Denervation System — Completed
• A Clinical Trial to Assess the Agent Paclitaxel Coated PTCA Balloon Catheter for the Treatment of Subjects With In-Stent Restenosis (ISR) — Running, not enrolling
• A Clinical Trial to Assess the Agent Paclitaxel Coated PTCA Balloon Catheter for the Treatment of Subjects With In-Stent Restenosis (ISR) - Long Lesion Cohort — Running, not enrolling
• Edwards PASCAL CLASP IID/IIF Pivotal Clinical Trial — Running, not enrolling
• A Pivotal Investigational Device Exemption Study on Laminar Left Atrial Appendage Elimination — Paused
• Light-Activated Antimicrobial Therapy to Prevent Surgical Site Infections — Completed
• Real World Registry for Use of the Ion Endoluminal System — Running, not enrolling
• INitiation and Titration of Guideline Directed Medical TheRApy in HearT Failure Cardiogenic Shock With ImpElla 5.5 for Cardiac Recovery — Starting soon
• Primary Unloading and Delayed Reperfusion in ST-Elevation Myocardial Infarction: The STEMI-DTU Trial — Running, not enrolling
• Abbott Atrial Fibrillation Post Approval Study — Running, not enrolling
• HEAL-LAA Clinical Trial — Completed
• Comparison of Anticoagulation With Left Atrial Appendage Closure After AF Ablation — Completed
• Beating Heart Mitral Valve Repair With the HARPOON™ System — Running, not enrolling
• Reducing Lung CongestIon Symptoms in Advanced Heart Failure — Running, not enrolling
• Portico Re-sheathable Transcatheter Aortic Valve System US IDE Trial — Running, not enrolling
• Controlled Arterial Protection to Ultimately Remove Embolic Material — Completed
• Mupirocin-Iodophor ICU Decolonization Swap Out Trial — Completed
• SPYRAL PIVOTAL - SPYRAL HTN-OFF MED Study — Completed
• Trifecta™ GT Post Market Clinical Follow-up — Completed
• A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-mediated COVID-19 in Adults — Completed
• Distal Evaluation of Functional Performance with Intravascular Sensors to Assess the Narrowing Effect: Guided Physiologic Stenting — Enrolling by invitation
• CLUSTER Trial for Outbreak Detection and Response — Completed
• A Trial of PF-07901800 (TTI-621) for Patients With Hematologic Malignancies and Selected Solid Tumors — Stopped early
• Pexelizumab in Conjunction With Angioplasty in Acute Myocardial Infarction (APEX-AMI) — Completed
• Evaluation of Treatment Strategies for Severe CaLcIfic Coronary Arteries: Orbital Atherectomy vs. Conventional Angioplasty Technique Prior to Implantation of Drug-Eluting StEnts: The ECLIPSE Trial — Running, not enrolling
• A Study Evaluating Intensive Chemotherapy With or Without Glasdegib or Azacitidine With or Without Glasdegib In Patients With Previously Untreated Acute Myeloid Leukemia — Completed
• AMBULATE: Cardiva Mid-Bore VVCS vs. Manual Compression for Multiple Femoral Venous Access Sites, 6 - 12F ID — Completed
• PROTECTED TAVR: Stroke PROTECTion With SEntinel During Transcatheter Aortic Valve Replacement — Completed
• REPRISE IV: LOTUS Edge Valve System in Intermediate Surgical Risk Subjects — Stopped early
• SHIELD II Clinical Investigation — Stopped early
• XIENCE 28 USA Study — Completed
• Tack Optimized Balloon Angioplasty Study of the Tack Endovascular System® in Below the Knee Arteries — Completed
• TactiCath® Contact Force Ablation Catheter Study for Atrial Fibrillation Post Approval Study — Completed
• Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure — Completed
• EVOLVE Short DAPT Study — Completed
• A Study To Evaluate PF-04449913 With Chemotherapy In Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome — Completed
• Medtronic Resolute Onyx 2.0 mm Clinical Study — Completed
• Medtronic RESOLUTE ONYX Core (2.25 mm - 4.0 mm) Clinical Study — Completed
• Irrigated Ablation System Evaluation for Atrial Fibrillation (AF) — Completed
• DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation — Stopped early
• The EVOLVE II Clinical Trial To Assess the SYNERGY Stent System for the Treatment of Atherosclerotic Lesion(s) — Completed
• Cluster Randomized Trial of Hospitals to Assess Impact of Targeted Versus Universal Strategies to Reduce Methicillin-resistant Staphylococcus Aureus (MRSA) in Intensive Care Units (ICUs) — Completed